12h20
Registration
12h50
Welcome Address
13h00
Opening Keynote Lecture
Hervé Broly
Executive CMC Consultant for Biologics
Merck-Serono SA, Switzerland
13h30
Coffee Break – Exhibition Hall – B2B Meetings
14h00
Track Reassessing Critical quality attributes (CQA ) for mAbs & Vaccines : latest developments
Alain Beck
Senior Director, Biologics CMC & Developability
Pierre Fabre, France
Associate editor
mAbs
Koen Sandra
CEO
RIC group, Belgium
Kowid Ho
Technical Regulatory (CMC) Policy Biologics
F. Hoffmann-La Roche Ltd., Switzerland
Michel Sachpekidis
Business Development Manager
Optimal Industrial Technologies
Philippe Grimm
Business Development & Marketing Director
SGS
Christelle Dagoneau
VP, Global Biologics Business Development
Just Evotec
Track Critical quality attributes (CQA) for Cell & Gene Therapy : new advancements
Olivier Maurion
Director « GoCommercial » Project
Yposkesi, France
François Gianelli
Senior Director CMC
Voisin Consulting Life Sciences
Michel Degueldre
Lead GT Analytics Physico-Chemical methods
UCB Pharma, Belgium
Antoine Heron
Cell & Gene Therapy Bioprocessing
Merck, France
Emmanuelle Cameau
Strategic Technology Partnership Leader
PALL
15h20
Track Process characterization and validation for mAbs and Vaccins : case-studies
Elodie Lim
Upstream Process Engineer
SANOFI
Marine De-Jaeger
USP Engineer
SANOFI
Thibault Lasgouzes
Downstream Process Expert 2
Novartis
Pierre Moretti
Director - Head of BPS process design
MERCK, Switzerland
Léa Bourigault
Upstream process PhD student
SANOFI, France
Track Process characterization and validation for cell & gene therapy : case-studies
Gregory Berger
Principal Scientist Cell & Gene Therapy
Celonic, Switzerland
Guillaume Sirgue
Head of BioManufacturing and Process Development Operations
ABL Europe Lyon
Yolla German
Field Application Scientist
Chemometec
William Small
Research & Technology Specialist
Croda Pharma
Florent Belon
CEO - Co-Founder - Commercial Director
Cell&Co, France
Auguste Attenot
VectorBuilder
16h40
Coffee Break – Exhibition Hall – B2B Meetings
17h10
Breakthrough Innovations in Bioproduction
Charles Hébert
CEO
GenSensor
Elodie Paquier
R&D Director
Bio Elpida, France
Robert Mamoun
CEO and co-founder
Ciloa, France
Anja Müller
Managing Director
IRUBIS GmbH, Germany
Paul Kauffmann
President
MagIA Diagnostics
17h50
Round table: How to bring single-use disposables and consumables suppliers back to Europe: challenges & opportunites
Eric Kummer
Head Of Operations BPS
Sartorius, France
Eva Schaefer
Director Supply Robustness
Merck KGaA, Germany
Roland Beliard
CEO
LFB Biomanufacturing, France
19h00
Poster presentation- Exhibition Hall – Apero Cocktail
8h00
Welcome coffee
9h00
Track Stability studies of cell lines to speed up first in human trials: new technologies & approaches
Julien Douet
Head Cell Line Technologies
Merck
Regina Grillari
COO, CSO, co-founder
Evercyte
Amina Cherif Louazani
Viral Safety Manager
Pathoquest
Cyndie Forestier
Scientific Account Manager
Genomic Vision
Quentin Ueberschlag
Senior Scientist
Celonic, Switzerland
Track Viral Clearance in the Manufacture of Biologics: next generation strategies
Eric Forma
DSP Principal Scientist – Global Bioprocess Development
Sanofi
Fabien Barbirato
mRNA Techno Platform CMC Leader
Sanofi
Anne Fournillier
Head of CMC Life Cycle Management, Pediatric and Booster vaccines
Sanofi
Cristina Barbirato
Scientific and Regulatory Expert for Biological Quality Control - Senior Scientist
Merck
Sandra Bosshard
Team Lead - cell Culture Development
Lonza, Switzerland
Maja Leskovec
Head of PC3 Process Development Viruses
Sartorius
10h20
Coffee Break – Exhibition Hall – B2B Meetings
11h00
Parallell Workshops
12h30
Lunch– Exhibition Hall – B2B Meetings
14h15
Title to be announced
Jacques Volkmann
Vice President, Sanofi R&D France et Président France Biolead
France
14h30
Keynote Lecture
Xavier Berthet
Director - Biomedical Research
Institut Pasteur de Dakar, Sénégal
15h00
Breakthrough Innovations in Bioproduction
Koen Dierckx
co-founder and CEO
simAbs, Belgium
Valentine Tingaud
PhD Student Process Development
Université Claude Bernard Lyon 1, France
Alexandre Callot
Senior Technical Sales Specialist
ThermoFisher
Tarek Fathallah
CEO
Carroucell
Manuel Vega
Founder CEO
AGS, France
15h35
Track mRNA, a new platform technology and therapeutical approach: pros & cons
Nicolas Chaudet
Bioprocess R&D Unit head (microbiology / mRNA)
SANOFI
Jose Castillo
CEO
Quantoom Biosciences
Arslan Akmammedov
Principal Scientist
Celonic
Pascale Bouillé
CEO
Flash Therapeutics, France
16h55
Closing remarks
17h00
Exhibition Hall – B2B Meetings
18h00
End of Congress
Submit your Abstract to give a Pitch presentation or present your Poster at the 7th edition Bioproduction Congress.
In order to provide visibility and promote innovation in the field of “CMC Readiness to accelerate biotherapeutics for patients”, a call is open to submit an abstract for a Pitch at Breakthrough Innovations in Bioproduction Session.
This is a great opportunity for start-ups, SMEs, and academic laboratories to share their new work!
The abstracts will be reviewed and the best selected for innovative products, technology, approaches and research.
Abstract submission deadline extended: July 29th, 2022
Check out the guidelines and fill-in the Abstract Form and send it to ana-sofia.antunes@mabdesign.fr
Abstract Submission Guidelines
Abstract Form